Twinstrand Therapeutics http://www.twinstrand.com/ en-us 2007-02-02T08:00:00-08:00 Board of Directors http://www.twinstrand.com/archives/000059.php Julia Levy, PhD, Director
Jeanne Bertonis, Director
Pat Brady, Director
Donna Parr, Director
Thor J Borgford, PhD, Director]]> Company caroline 2007-02-02T08:00:00-08:00 Scope of Research http://www.twinstrand.com/archives/000066.php Prodrug Mechanism
Therapeutics for Cancer
Therapeutics for Other Indications]]> Research caroline 2006-09-22T13:50:00-08:00 Management http://www.twinstrand.com/archives/000005.php Larry Gontovnick, Vice President of Drug Development
Curtis Braun, Vice President of Operations
Marjorie Co, Director of Business Development]]> Company twinstrand 2006-09-11T17:30:00-08:00 Clinical and Scientific Advisors http://www.twinstrand.com/archives/000006.php Gail Eckhardt, MD
Lia Gore, MD
Bruce Silver, MD, FACP
Robert B. Royds, MB, BS, MRCP
Professor Kenneth R. Harrap, CBE, PhD, DSc, FRSC, SAB Chair
Deborah Ramsdell]]> Company twinstrand 2006-09-11T17:00:00-08:00 Pipeline http://www.twinstrand.com/archives/000063.php Biodefense: ricin countermeasures
Viral & parasitic diseases]]> Research caroline 2006-09-11T16:30:00-08:00 Current Alliances http://www.twinstrand.com/archives/000004.php NIAID
Eurogentec SA
Princess Margaret Hospital, Toronto
University of Colorado Cancer Center
BC Cancer Agency
Defense Research Establishment, Government of Canada
National Microbiology Laboratory, Health Canada
]]> Partners twinstrand 2006-09-06T16:30:00-08:00 Highlights http://www.twinstrand.com/archives/000010.php - US$1.9M contract from US Department of Defense for the development of Antibody-Based Countermeasures to Ricin Poisoning]]> Company twinstrand 2006-09-05T16:00:00-08:00 History http://www.twinstrand.com/archives/000008.php 1995: The company, a spin-off from the Department of Molecular Biology and Biochemistry at Simon Fraser University, is incorporated Company twinstrand 2006-06-30T15:00:00-08:00 Investors http://www.twinstrand.com/archives/000009.php Twinstrand Therapeutics is a private-owned biopharmaceutical company focused on discovering and developing targeted prodrugs. Company twinstrand 2006-06-30T15:00:00-08:00 Opportunity http://www.twinstrand.com/archives/000015.php Twinstrand prodrugs are activated by proteases, which have well-established roles in numerous diseases. Though now focused on the development of drugs for the treatment of cancer, the company has a product platform with broad potential in the treatment of diseases... Applications twinstrand 2004-02-01T20:50:03-08:00 Careers http://www.twinstrand.com/archives/000013.php At Twinstrand we are at the forefront of new technologies for the treatment of human diseases. Our passion for scientific innovation and commitment to corporate growth and sustained commercial success are fostered in a friendly, supportive atmosphere, making Twinstrand a special place to work. Company twinstrand 2004-02-01T15:08:43-08:00